CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 143,300 | $11,464,000 | 11.16% |
| Hillhouse Capital Management | 2,751,200 | $220,096,000 | 5.88% |
| York Capital Management Global Advisors, LLC | 1,167,643 | $93,411,000 | 2.95% |
| Kite Lake Capital Management (UK) LLP | 152,836 | $12,227,000 | 2.53% |
| RUDMAN ERROL M | 80,000 | $6,400,000 | 2.39% |
| Dalton Investments, Inc. | 54,551 | $4,364,000 | 2.04% |
| Greenwoods Asset Management Ltd | 245,000 | $19,600,000 | 1.91% |
| Point72 Hong Kong Ltd | 47,296 | $3,784,000 | 1.29% |
| Temasek Holdings (Private) Ltd | 990,000 | $79,200,000 | 0.46% |
| Kassirer Asset Management Corp | 6,000 | $480,000 | 0.32% |